2024-03-29T09:22:05Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_5E664B01B65D
2024-03-23T02:25:57Z
serval:BIB_5E664B01B65D
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
10.1053/j.gastro.2022.09.005
36108710
Haber
P.K.
author
Castet
F.
author
Torres-Martin
M.
author
Andreu-Oller
C.
author
Puigvehí
M.
author
Miho
M.
author
Radu
P.
author
Dufour
J.F.
author
Verslype
C.
author
Zimpel
C.
author
Marquardt
J.U.
author
Galle
P.R.
author
Vogel
A.
author
Bathon
M.
author
Meyer
T.
author
Labgaa
I.
author
Digklia
A.
author
Roberts
L.R.
author
Mohamed Ali
M.A.
author
Mínguez
B.
author
Citterio
D.
author
Mazzaferro
V.
author
Finkelmeier
F.
author
Trojan
J.
author
Özdirik
B.
author
Müller
T.
author
Schmelzle
M.
author
Bejjani
A.
author
Sung
M.W.
author
Schwartz
M.E.
author
Finn
R.S.
author
Thung
S.
author
Villanueva
A.
author
Sia
D.
author
Llovet
J.M.
author
article
2023-01
Gastroenterology
1528-0012
0016-5085
journal
164
1
72-88.e18
Humans
Carcinoma, Hepatocellular/drug therapy
Carcinoma, Hepatocellular/genetics
Carcinoma, Hepatocellular/metabolism
Liver Neoplasms/drug therapy
Liver Neoplasms/genetics
Liver Neoplasms/metabolism
Programmed Cell Death 1 Receptor/metabolism
Prospective Studies
Biomarkers
Hepatocellular Carcinoma
Immunotherapy
Predictors of Response
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish